Article / Topic
|
Issue
|
|
Advocacy
|
|
|
Activists sue South
Africa*
|
Nov/Dec
|
|
Five steps to effective AIDS advocacy
|
Jan/Feb
|
|
How to be a player in federal decision-making
|
Sep/Oct
|
|
How you can help ACT UP*
|
Jan/Feb
|
|
New treatment advocacy group*
|
Nov/Dec
|
|
Scarlet Letter: A college campus AIDS
advocate speaks out
|
Mar/Apr
|
|
UN session on AIDS*
|
Sep/Oct
|
|
Young AIDS activist laid to rest*
|
Jul/Aug
|
|
Children
|
|
|
Pharmacy considerations for pediatric
HIV
|
May/Jun
|
|
Clinical trials
|
|
|
HIV vaccine study
|
Mar/Apr
|
|
Marijuana study*
|
Jan/Feb
|
|
Oral ulcers*
|
May/Jun
|
|
Research rights and responsibilities
|
May/Jun
|
|
T-20 and tenofovir expanded access*
|
May/Jun
|
|
Combination therapy
|
|
|
Combination dosage adjustment drug chart
|
Jan/Feb
|
|
Commentary
|
|
|
Living with HIV
|
Nov/Dec
|
|
Positive empowerment
|
Nov/Dec
|
|
Rituals and regimens 2001
|
Jan/Feb
|
|
Complementary therapy
|
|
|
For people living with HIV
|
Jan/Feb
|
|
Reiki
|
Nov/Dec
|
|
Conferences
|
|
|
Straight retreat*
|
May/Jun
|
|
Update from the 8th Retrovirus Conference
|
Mar/Apr
|
|
Cultural issues
|
|
|
HIV in rural America
|
Nov/Dec
|
|
Drug compliance
|
|
|
Adherence 101
|
Sep/Oct
|
|
Drug holidays and lipodystrophy
|
Jan/Feb
|
|
Drug interactions
|
|
|
Cipro and methadone don’t mix*
|
Mar/Apr
|
|
Drug side effects
|
|
|
Crix stones*
|
Mar/Apr
|
|
HIV drugs and insulin resistance*
|
Sep/Oct
|
|
Lactic acid and liver problems*
|
Sep/Oct
|
|
Protease inhibitor artery damage*
|
Jan/Feb
|
|
Side effects management*
|
Nov/Dec
|
|
Viramune liver warning*
|
Jan/Feb
|
|
Zerit, Videx and hydroxyurea*
|
Mar/Apr
|
|
Drugs
|
|
|
Agenerase (amprenavir) fact sheet
|
Jan/Feb
|
|
Anti-retroviral drug tips
|
Jan/Feb
|
|
Crixivan (indinavir) fact sheet
|
Jan/Feb
|
|
Crixivan fact sheet manufacturer statement*
|
Mar/Apr
|
|
Epivir (3TC) fact sheet
|
Jan/Feb
|
|
Faster approval of HIV drugs for patients
with resistance
|
Mar/Apr
|
|
FDA cracks down on HIV drug ads*
|
Jul/Aug
|
|
Fortovase (saquinavir soft-gel) fact sheet
|
Jan/Feb
|
|
Hivid (ddc) fact sheet
|
Jan/Feb
|
|
How HIV drugs work 101
|
Sep/Oct
|
|
Hydrea/Droxia (hydroyurea) fact sheet
|
Jan/Feb
|
|
Kaletra (lopinavir/ritonavir) fact sheet
|
Jan/Feb
|
|
Marinol–marijuana in a bottle*
|
Jul/Aug
|
|
Norvir (ritonavir) fact sheet
|
Jan/Feb
|
|
Rescriptor (delavirdine) fact sheet
|
Jan/Feb
|
|
Retrovir (AZT) fact sheet
|
Jan/Feb
|
|
Sustiva (efavirenz) fact sheet
|
Jan/Feb
|
|
Sustiva better at lowering viral load*
|
Jul/Aug
|
|
Sustiva one tablet formulation soon*
|
Jul/Aug
|
|
T-20/pentafuside fact sheet
|
Jan/Feb
|
|
tenofovir fact sheet [Viread]
|
Jan/Feb
|
|
tenofovir update* [Viread]
|
Jul/Aug
|
|
tipranavir fact sheet
|
Jan/Feb
|
|
Trizivir: One pill, triple combination*
|
Jan/Feb
|
|
Videx (ddI) fact sheet
|
Jan/Feb
|
|
Viracept (nelfinavir) fact sheet
|
Jan/Feb
|
|
Viramune (nevirapine) fact sheet
|
Jan/Feb
|
|
Viread (tenofovir DF) new drug*
|
Nov/Dec
|
|
When to start therapy
|
Sep/Oct
|
|
Zerit (d4T) fact sheet
|
Jan/Feb
|
|
Ziagen (abacavir) fact sheet
|
Jan/Feb
|
|
Entertainment
|
|
|
Magic Johnson shines*
|
Nov/Dec
|
|
Financial issues
|
|
|
HIV drug price in Brazil*
|
Nov/Dec
|
|
Understanding prescription benefits
|
Jul/Aug
|
|
Funding
|
|
|
Ryan White CARE Act passes*
|
Jan/Feb
|
|
Healthcare
|
|
|
Gay and lesbian healthcare needs improving*
|
Sep/Oct
|
|
Hemophilia
|
|
|
Relief fund*
|
Jan/Feb
|
|
Hepatitis
|
|
|
HCV/HIV co-infections
|
Sep/Oct
|
|
Rebetron for hep C*
|
Sep/Oct
|
|
HIV basics
|
|
|
Adherence 101
|
Sep/Oct
|
|
HIV 101 for women
|
Sep/Oct
|
|
HIV case management 101
|
Sep/Oct
|
|
How HIV drugs work 101
|
Sep/Oct
|
|
Opportunistic infections 101
|
Sep/Oct
|
|
What is AIDS?
|
Sep/Oct
|
|
When to start therapy
|
Sep/Oct
|
|
HIV complications
|
|
|
Abnormal enlargement of breast tissue
seen in men
|
Nov/Dec
|
|
HIV prevention
|
|
|
Condoms are good*
|
Nov/Dec
|
|
Internet prevention messages*
|
Jan/Feb
|
|
San Francisco AIDS Foundation campaign*
|
May/Jun
|
|
San Francisco Health Department survey*
|
May/Jun
|
|
Survey results*
|
Nov/Dec
|
|
HIV research
|
|
|
Mozenavir experimental drug problems
|
Mar/Apr
|
|
HIV transmission
|
|
|
Circuit party transmission survey*
|
Sep/Oct
|
|
Lubes may help prevent transmission*
|
Nov/Dec
|
|
Nonoxynol-9 increases HIV risk from anal
sex*
|
Mar/Apr
|
|
Oral sex safe?
|
Nov/Dec
|
|
HIV treatment
|
|
|
2000: A year of endings and beginnings
|
Jan/Feb
|
|
Antiretroviral therapy 2001
|
Jan/Feb
|
|
HIV guidelines now say “hit later”*
|
Mar/Apr
|
|
HIV specialty center opens*
|
Mar/Apr
|
|
HIV/AIDS specialists*
|
Jul/Aug
|
|
Rescue regimens: The value of PI boosting
|
Nov/Dec
|
|
The importance of sequencing in treatment
options
|
May/Jun
|
|
The ups and downs of drug levels
|
May/Jun
|
|
Viramune not for PEP*
|
Mar/Apr
|
|
HIV vaccine
|
|
|
Remune bites the dust…again
|
Sep/Oct
|
|
Lactic acidosis
|
|
|
Treatment of*
|
Mar/Apr
|
|
Legal issues
|
|
|
Award to man refused treatment*
|
Mar/Apr
|
|
Grocery settles discrimination lawsuit
|
Jul/Aug
|
|
HIV drug companies sue South African government*
|
Mar/Apr
|
|
Medicinal marijuana for Hawaii*
|
Mar/Apr
|
|
Pharmaceuticals drop lawsuit against South
Africa*
|
Jul/Aug
|
|
Lipodystrophy
|
|
|
Drug holidays & lipodystrophy
|
Jan/Feb
|
|
New facial filling treatment for lipodystrophy
|
Sep/Oct
|
|
New-fill polylactic acid available for
facial surgery*
|
Jul/Aug
|
|
Polylactic acid for facial filling*
|
Mar/Apr
|
|
Mental health
|
|
|
Abusive behaviors and HIV
|
Nov/Dec
|
|
AIDS and depression linked*
|
Nov/Dec
|
|
Detection and treatment of depression
|
Nov/Dec
|
|
Minority issues
|
|
|
Black AIDS gets less money*
|
Jan/Feb
|
|
Neuropathy
|
|
|
New book available*
|
Jul/Aug
|
|
Opportunistic infections
|
|
|
New AIDS cancer*
|
Jul/Aug
|
|
AIDS lymphoma still up*
|
Mar/Apr
|
|
Fungal infections
|
May/Jun
|
|
Opportunistic infections 101
|
Sep/Oct
|
|
Stopping PCP meds*
|
Mar/Apr
|
|
Osteopenia
|
|
|
Lactic acid and bone problems*
|
Sep/Oct
|
|
Reports of abnormal changes in HIV
|
Jul/Aug
|
|
Pets
|
|
|
Here, kitty kitty: Why pets are good for
you
|
Mar/Apr
|
|
Pregnancy
|
|
|
Lactic acidosis warning*
|
Mar/Apr
|
|
Pregnant women should get tested*
|
Jan/Feb
|
|
Updated guidelines for HIV drugs in pregnancy*
|
Sep/Oct
|
|
Prison issues
|
|
|
Death of another woman prisoner
|
Jul/Aug
|
|
From a positive prisoner
|
Jul/Aug
|
|
HIV incarcerated women
|
Jul/Aug
|
|
HIV prevention for inmates*
|
Jul/Aug
|
|
HIV treatment in prison
|
Jul/Aug
|
|
Inmate resource guide
|
Jul/Aug
|
|
Positive women prisoners speak out
|
Jul/Aug
|
|
Recommendations for HIV-positive inmates
|
Jul/Aug
|
|
Sustiva “dirty drops” put prisoners in
solitary
|
Nov/Dec
|
|
Women incest survivors in prison
|
Jul/Aug
|
|
Resistance
|
|
|
Forty percent drug resistance estimated*
|
Nov/Dec
|
|
HIV “superbug”?*
|
Nov/Dec
|
|
Phenotypic resistance test news*
|
Jan/Feb
|
|
Understanding HIV/AIDS drug resistance
assays
|
Jan/Feb
|
|
Resources
|
|
|
FDA HIV e-mail list*
|
Nov/Dec
|
|
Glossary
|
Jan/Feb
|
|
Positively Aware 2000 index
|
Jan/Feb
|
|
Structured Treatment
Interruptions (STIs)
|
|
|
Guidelines updated to include info on
stopping therapy*
|
Nov/Dec
|
|
Sloppy treatment impulses
|
Sep/Oct
|
|
Substance use
|
|
|
Methadone cuts mortality*
|
Sep/Oct
|
|
One in 62: Young injectors
|
Mar/Apr
|
|
Syringe exchange programs slow rate of
infection*
|
Nov/Dec
|
|
Women
|
|
|
Are you getting good medical care?
|
May/Jun
|
|
Body changes*
|
Nov/Dec
|
|
Cesarean complications*
|
Sep/Oct
|
|
Get me some self-esteem
|
Jul/Aug
|
|
HIV 101 for women
|
Sep/Oct
|
|
Nutrition in HIV positive women
|
May/Jun
|
|
One on one with Earlene Hayden
|
May/Jun
|
|
One on one with Leatrice Simpson
|
May/Jun
|
|
One on one with Syliva O’Shaughnessy
|
May/Jun
|
|
Pap smear primer
|
May/Jun
|
|
Pap smears for survivors of sexual abuse
|
May/Jun
|
|
T-cells, viral load and progression*
|
Jul/Aug
|
|
Thank God for women’s health activists!
|
Jan/Feb
|
|
Viramune rash seen more in women*
|
Mar/Apr
|
|
Women’s news
|
May/Jun
|
|
Youth
|
|
|
Lost youth
|
Mar/Apr
|
|
One in 62: Young injectors
|
Mar/Apr
|
| Scarlet Letter: A college campus
AIDS advocate speaks out |
Mar/Apr
|
